Key result
Regular aspirin use was associated with an increased risk of developing Crohn's disease, but not ulcerative colitis.
Why the study?
Does regular aspirin use increase the risk of developing Crohn's disease or ulcerative colitis in adults aged 30-74 years?
Cohort (n=135,780)
Yes
Does regular aspirin use increase the risk of developing Crohn's disease or ulcerative colitis in adults aged 30-74 years?
Regular aspirin use is strongly associated with an increased risk of developing Crohn's disease, but not ulcerative colitis, in a European cohort.
Answers are grounded in this paper and cite their sources.
May warrant aspirin caution in IBD-prone patients; leaves open causality and need for confirmatory trials.
BACKGROUND: Aspirin has detrimental effects on the gastrointestinal tract mucosa and may play a role in the aetiology of inflammatory bowel disease. AIM: To investigate if the regular use of aspirin is associated with the development of Crohn's disease (CD) and ulcerative colitis (UC) using, for the first time, a prospective cohort study design. METHODS: A total of 135,780 men and women in Europe, aged 30-74years, were recruited into the European Prospective Investigation into Cancer and Nutrition study. Participants completed questionnaires at baseline detailing their regular aspirin use and were then followed up to identify those who developed either incident CD or UC. Each case was matched with four controls and odds ratios (OR) were calculated, adjusting for cigarette smoking. Potential interactions between aspirin and smoking were assessed. RESULTS: A total of 35 participants developed CD and a further 84 were diagnosed with UC. Regular aspirin intake was positively associated with the risk of developing CD (OR=6.14, 95% CI=1.76-21.35). In those who took aspirin and smoked there was no detectable increased risk of CD (OR=0.30, 95% CI=0.03-3.08). No association was found between regular aspirin use and UC (OR=1.29, 95% CI=0.67-2.46). CONCLUSIONS: A strong positive association between regular aspirin use and CD, but not UC, was observed. The data suggest that regular aspirin use should be measured in epidemiological work on CD. If such findings are consistent in other work then aspirin may affect the development of CD in a middle-aged to elderly population.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2011) conducted a cohort in Crohn's disease and ulcerative colitis (n=135,780). Regular aspirin use vs. No regular aspirin use was evaluated on Development of Crohn's disease (OR 6.14, 95% CI 1.76-21.35). Regular aspirin use was associated with an increased risk of developing Crohn's disease, but not ulcerative colitis.
Synapse has enriched 10 related papers. Consider them for comparative context: